Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients
Luz María Medrano, Pilar García‐Broncano, Juan Berenguer, et al.
AIDS (2018) Vol. 32, Iss. 9, pp. 1095-1105
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases
Vincent Mittelheisser, Valentin Gensbittel, Lucia Bonati, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 3, pp. 281-297
Closed Access | Times Cited: 25
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
Murali Ganesan, Larisa Y. Poluektova, Kusum K. Kharbanda, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 4, pp. 398-410
Open Access | Times Cited: 59
Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
Duale Ahmed, David Roy, Edana Cassol
Mediators of Inflammation (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 48
Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy
Lenche Kostadinova, Carey L. Shive, Elizabeth Zebrowski, et al.
Pathogens and Immunity (2018) Vol. 3, Iss. 1, pp. 149-149
Open Access | Times Cited: 39
Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review
Ahmed Babiker, Mohamed Hassan, Safwan Muhammed, et al.
Clinical Cardiology (2019) Vol. 43, Iss. 3, pp. 222-234
Open Access | Times Cited: 26
Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study
Luz María Medrano, Juan Berenguer, Sergio Salgüero, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 18
Matrix stiffness regulate apoptotic cell death in HIV-HCV co-infected hepatocytes: Importance for liver fibrosis progression
Murali Ganesan, Raghubendra Singh Dagur, Edward Makarov, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 500, Iss. 3, pp. 717-722
Open Access | Times Cited: 22
HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
Óscar Brochado-Kith, Isidoro Martínez, Juan Berenguer, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 17
Impact of HIV infection on aging and immune status
José Ramón Blanco, Eugènia Negredo, Enrique Bernal, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 6, pp. 719-731
Closed Access | Times Cited: 17
Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status
Pilar García‐Broncano, Luz María Medrano, Juan Berenguer, et al.
Cells (2018) Vol. 7, Iss. 11, pp. 196-196
Open Access | Times Cited: 18
Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients
Ana Virseda‐Berdices, David Rojo, Isidoro Martínez, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112623-112623
Open Access | Times Cited: 8
Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study
Pilar García‐Broncano, Luz María Medrano, Juan Berenguer, et al.
Journal of Infection (2019) Vol. 80, Iss. 1, pp. 99-110
Open Access | Times Cited: 13
PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study
Sergio Salgüero, Óscar Brochado-Kith, Ana Virseda Verdices, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114220-114220
Open Access | Times Cited: 4
Association of serum lipid profile with liver fibrosis in HCV‑coinfected HIV patients on suppressive anti‑retroviral therapy
Somkid Srisopa, Duangnate Pipatsatitpong, Chareeporn Akekawatchai
Biomedical Reports (2024) Vol. 21, Iss. 4
Open Access | Times Cited: 1
Mechanotransduction of liver sinusoidal endothelial cells under varied mechanical stimuli
Xinyu Shu, Ning Li, Yi Wu, et al.
Acta Mechanica Sinica (2021) Vol. 37, Iss. 2, pp. 201-217
Closed Access | Times Cited: 10
Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients
Ana Carrero, Juan Berenguer, Víctor Hontañón, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2020) Vol. 83, Iss. 3, pp. 292-300
Open Access | Times Cited: 10
Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study
Sergio Salgüero, Luz María Medrano, Juan González‐García, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
Sonia Vázquez‐Morón, Juan Berenguer, Juan González‐García, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
Beatriz Álvarez, Clara Restrepo, Marcial García, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 323-323
Open Access | Times Cited: 7
Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV–HCV-Coinfected Individuals
Xiaochen Chen, Xing Liu, Song Duan, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 24, pp. 9474-9474
Open Access | Times Cited: 7
Hepatitis B core antibody and liver stiffness measurements predict HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with minimally elevated alanine aminotransferase (ALT) levels
Xihua Fu, Haibo Lou, Fang Chen, et al.
Clinical and Experimental Medicine (2020) Vol. 20, Iss. 2, pp. 241-248
Closed Access | Times Cited: 4
Significance of Vascular Cell Adhesion Molecule-1 and Tumor Necrosis Factor-Alpha in HIV-Infected Patients
Tomasz Mikuła, Magdalena Suchacz, Mariusz Sapuła, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 514-514
Open Access | Times Cited: 3
Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV
Giulia Morsica, Laura Galli, Emanuela Messina, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0262917-e0262917
Open Access | Times Cited: 3
Immune Biomarker Changes in HIV/HCV-Coinfected Individuals After Direct-Acting Antiviral Treatment: A Prospective Study in Indonesia
Evy Yunihastuti, Youdiil Ophinni, Vidya Sari, et al.
(2024)
Closed Access
Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study
Daniel Sepúlveda‐Crespo, Camilla Volpi, Rafael Amigot‐Sánchez, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1152-1152
Open Access
Page 1 - Next Page

Scroll to top